BofA analyst Peter Galbo lowered the firm’s price target on Procter & Gamble to $167 from $171 and keeps a Buy rating on the shares. The firm maintains its Q3 EPS forecast at $1.55, but lowers its FY26 and FY27 estimates to reflect an increased resin cost view, the analyst tells investors in a preview.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target lowered to $167 from $172 at RBC Capital
- Procter & Gamble recommends stockholders reject mini-tender offer by Potemkin
- Procter & Gamble price target lowered to $158 from $177 at Wells Fargo
- Procter & Gamble price target lowered to $142 from $150 at Piper Sandler
- Procter & Gamble price target lowered to $166 from $170 at UBS